10d
First for Women on MSNLa La Anthony on Her Plaque Psoriasis: ‘It Doesn't Have To Hold You Back'Since revealing her plaque psoriasis diagnosis in 2015, La La Anthony has become a powerful voice for those living with the ...
Between 45-56% of people living with psoriasis may experience these symptoms affecting the scalp, hairline, forehead, back of the neck and around the ears. Treatment includes use of over-the ...
Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a ...
Knowing which kind of psoriasis you have helps you and your doctor make a treatment plan. Most people have only one type at a time. Experts believe psoriasis is an autoimmune disease.
J&J's head of immunodermatology Liza O'Dowd said that the "robust results" with its oral IL-23 drug have the potential to ...
Opens in a new tab or window Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed ...
Bristol Myers Squibb has released new 5-year results from the long-term trial evaluating Sotyktu for the treatment of adults ...
Alumis Inc.'s twice-a-day oral drug totally cleared the skin of telltale red, itchy patches in nearly 39% of 80 ...
Opens in a new tab or window Uncertainties remain about the real-world benefit of adalimumab biosimilars for psoriasis, limiting their widespread adoption. This analysis involving patients in the ...
Stress is a common trigger for psoriasis, and with so much uncertainty happening, my flare-ups came right back." This time around, though, Rimes has decided not to hide. She first revealed in 2008 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results